Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Common triggers like income changes or new expenses alert you to reallocate funds in your budget.
17,780 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
Dogecoin pulled back after a brisk rally, erasing part of yesterday's gains. This guide explains what caused the drop...
Prediction markets offer probabilities, not guarantees. This article explains what polymarket says bitcoin just 3% od...
Disruption is reshaping markets faster than ever. This article digs into disruption stories: stocks that could be at ...
A growing cohort of retirees is turning to a 3.56% yield strategy as grocery bills rise. The Invesco DBA ETF provides...
The Real Brokerage is expanding its leadership with the appointment of Jason Cassity as Chief Growth Officer, a move ...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
A universal technical institute director recently sold 10,000 shares, sparking questions about what it means for UTI ...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
Rivian stock rallied today as investors weighed new partnerships, production progress, and autonomous-driving milesto...